--- title: TRC Healthcare | Insights Newsletter July 2026 description: Get the top Letter articles for July, don't miss our upcoming live CE webinars, explore popular clinical resources, and more! --- [![TRC Healthcare](https://info.trchealthcare.com/hubfs/_TRC%20Logos%202022/TRC%20Healthcare/TRC%20Logo%20-%20LP.svg) ](https://trchealthcare.com/category/resources/) [![Insights: Emerging Trends for Clinical Leadership](https://info.trchealthcare.com/hs-fs/hubfs/trc_Insights_1300x300_text.png?width=1300&height=300&name=trc_Insights_1300x300_text.png) ](https://trchealthcare.com/insights-newsletter-july-2026-emerging-trends-for-clinical-leadership/) **July 2026** ### Updates You Don't Want Your Team to Miss Navigate Questions About the Medicare GLP-1 Bridge Program ** ** The Medicare GLP-1 Bridge launched July 1, 2026. This program allows eligible Medicare Part D patients to access certain GLP-1 medications for weight management for a $50 copay. Our articles explain which medications are included, which patients may qualify, and why prescriptions for indications such as type 2 diabetes, obstructive sleep apnea, or MASH should still be billed to Part D. We also outline how pharmacies should submit Bridge claims through CMS’s central processor, handle prior authorization, and counsel patients about copays, savings cards, and Part D cost-sharing limits. Your team can use our [*GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart*](https://pharmacist.therapeuticresearch.com/Home/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) to compare products and get guidance on switches. **Read More**: - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Articles/PLH/2026/Jul/Navigate-Questions-About-the-Medicare-GLP-1-Bridge) - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Articles/PTLH/2026/Jul/Navigate-Questions-About-the-Medicare-GLP-1-Bridge) - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Articles/PL/2026/Jul/Navigate-Questions-About-the-Medicare-GLP-1-Bridge) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Articles/PTL/2026/Jul/Navigate-Questions-About-the-Medicare-GLP-1-Bridge) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Articles/PRL/2026/Jul/Navigate-Questions-About-the-Medicare-GLP-1-Bridge) Community Pharmacies: Your Guide to Controlled Substance Rx Validation ** ** Controlled Rx fraud is becoming harder to spot as fraudsters get even more creative. Our articles explain how to evaluate controlled prescription legitimacy using green flags and caution flags. We also outline how PDMP checks can help identify concerning patterns and what to do when federal, state, or pharmacy policies differ. Readers dive deeper into federal controlled Rx laws with our CE course [*Controlled Substance Prescription Validation*](https://learning.therapeuticresearch.com/course/view.php?id=7317). **Read More**: - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Articles/PL/2026/Jul/Your-Complete-Guide-to-Controlled-Substance-Rx-Validation) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Articles/PTL/2026/Jul/Your-Complete-Guide-to-Controlled-Substance-Rx-Validation) Hospitals: Know the Latest Guidance to Help Improve Stroke Outcomes ** ** Hospital pharmacists should be ready to guide time-sensitive medication decisions for acute ischemic stroke. Our articles review when to use IV alteplase or tenecteplase, how to manage key risks such as recent DOAC use, and why add-on IV antithrombotics are not recommended to improve thrombolysis. We also outline practical monitoring steps, including BP and glucose targets, plus timing of antiplatelet therapy for secondary stroke prevention. For more guidance to optimize care, readers can access our [*Antiplatelets for Recurrent Ischemic Stroke*](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2015/Sep/Antiplatelets-for-Recurrent-Ischemic-Stroke-8855) chart and our [*Acute Ischemic Stroke Pharmacotherapy* *Checklist*](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2018/Jul/Acute-Ischemic-Stroke-Pharmacotherapy-Checklist-12496). **Read More**: - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Articles/PLH/2026/Jul/Guide-Medication-Therapy-for-Acute-Ischemic-Stroke) - [Hospital Pharmacy Technician's Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Articles/PTLH/2026/Jul/Timely-Meds-Are-Key-to-Survival-for-Ischemic-Strokes) ### Natural Medicines [![Caffeine](https://info.trchealthcare.com/hs-fs/hubfs/Caffeine.jpg?width=2000&name=Caffeine.jpg) ](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/July2026/Caffeine-Pouches-The-New-Nicotine) ### **Caffeine Pouches: The New Nicotine?** Caffeine pouches deliver rapid, high doses of caffeine and are gaining popularity among teens and young adults, raising serious safety concerns. Our [NatMed article](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/July2026/Caffeine-Pouches-The-New-Nicotine) breaks down how these products work and what to advise patients. Adults should stick to no more than 400 mg of caffeine daily, counting all sources. Kids and teens shouldn’t exceed 2.5 mg/kg daily – about 100 mg for the average 12-year-old – and should avoid these products altogether, especially given reports of pouches being distributed in schools. [![Caffeine](https://info.trchealthcare.com/hs-fs/hubfs/Caffeine.jpg?width=2000&name=Caffeine.jpg) ](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/July2026/Caffeine-Pouches-The-New-Nicotine) ### **Caffeine Pouches: The New Nicotine?** Caffeine pouches deliver rapid, high doses of caffeine and are gaining popularity among teens and young adults, raising serious safety concerns. Our [NatMed article](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/July2026/Caffeine-Pouches-The-New-Nicotine) breaks down how these products work and what to advise patients. Adults should stick to no more than 400 mg of caffeine daily, counting all sources. Kids and teens shouldn’t exceed 2.5 mg/kg daily – about 100 mg for the average 12-year-old – and should avoid these products altogether, especially given reports of pouches being distributed in schools. ### New Podcast! Natural Medicines: Evidence in Practice In our latest episode, [*Atorvastatin Interactions: Foods and Supplements to Watch For*](https://naturalmedicines.buzzsprout.com/2549833/episodes/19446519), NatMed editors Jeff Langford, Andrea Stafford, and Kelly Daniels break down clinically relevant interactions using atorvastatin as a case study—and show how to apply a practical framework for identifying, interpreting, and managing these interactions at the point of care. [![Podcast Episodes](https://no-cache.hubspot.com/cta/default/229441/d3049453-1bc9-4d89-b9fe-b0b6444a6713.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/d3049453-1bc9-4d89-b9fe-b0b6444a6713) ### **New on NatMed Pro: Content Updates** We're excited to share that we've launched a new Content Updates page on NatMed Pro that provides a real-time log of monographs recently reviewed and updated by our editorial team. Covering the past three months of updates, the page shows exactly which sections have changed—including Effectiveness, Safety, Adverse Effects, Drug Interactions, Dosing, and more—so you can quickly see what's new without digging through individual monographs. **[![Explore Content Updates](https://no-cache.hubspot.com/cta/default/229441/ab853200-99bd-45e9-8537-e3c48009b213.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/ab853200-99bd-45e9-8537-e3c48009b213)** ### Pharmacy and Prescriber Podcasts #### Medication Talk Listen to this month’s podcast episode, [*Hypertension Treatment Updates*](https://learning.therapeuticresearch.com/course/view.php?idnumber=26-627), as our expert panel breaks down what every clinician needs to know about the 2025 hypertension guidelines. You’ll hear them discuss what’s changed, some controversies, and other practical takeaways to optimize blood pressure management for your patients. All Medication Talk episodes offer CE credit to Pharmacist’s Letter and Prescriber Insights subscribers for 2 years after the episode release date. Go to the [CE/CME & Training Organizer](https://learning.therapeuticresearch.com/local/trc_courselist/library.php?opt_id=oeu1740668995814r0.009425414181391867) and search “podcast” to find available courses.   ![medication talk on phone with headphones ](https://info.trchealthcare.com/hs-fs/hubfs/medication%20talk%20on%20phone%20with%20headphones%20.png?width=1081&height=712&name=medication%20talk%20on%20phone%20with%20headphones%20.png) #### Rumor vs Truth Listen to the latest episode, [*Ivermectin*](https://learning.therapeuticresearch.com/course/view.php?idnumber=26-670), as our editors dig into what’s driving the buzz and what the evidence actually shows across a surprisingly wide range of uses. From viral misinformation to emerging global health research, they explore where ivermectin fits… and where it doesn’t. All Rumor vs Truth podcast episodes offer CE credit to subscribers for 2 years after their release date. Go to the [CE/CME & Training Organizer](https://learning.therapeuticresearch.com/local/trc_courselist/library.php?opt_id=oeu1740668995814r0.009425414181391867) and search “podcast” to find available courses. #### **Clinical Capsules** Listen to our latest bonus episode, [*Navigating the Medicare GLP-1 Bridge: What Pharmacy Teams Need to Know*](https://learning.therapeuticresearch.com/course/view.php?idnumber=26-653), as our Associate Editor and Clinical Pharmacist Vickie Danaher breaks down the new Medicare GLP-1 Bridge program—what it is, how it works, and what pharmacy teams need to know right now. All Clinical Capsules podcast episodes offer CE credit to subscribers for 2 years after their release date. Go to the [CE/CME & Training Organizer](https://learning.therapeuticresearch.com/local/trc_courselist/library.php?opt_id=oeu1740668995814r0.009425414181391867) and search “podcast” to find available courses. ### Upcoming Live CE Webinars for Your Clinicians **Decoding the Lipid Guidelines: What’s New, What’s Debated, and What to Do** **Dates: ****July 21 & 23**  In this month's [live webinar](https://learning.therapeuticresearch.com/course/view.php?id=7441), *Decoding the 2026 Lipid Guidelines: What's New, What's Debated, and What to Do*, you'll hear our panelists discuss significant updates to managing dyslipidemia, from lower LDL targets and earlier treatment to new testing recommendations. And you'll listen as our panelists debate whether the evidence supports the guideline's aggressive new stance on primary prevention, including the move to the PREVENT risk calculator, the expansion of coronary artery calcium (CAC) scoring, and the new push to measure lipoprotein(a) in every adult patient. Our panelists will also take a critical look at the real-world practicality of these recommendations for busy clinicians. Available for APRNs, pharmacists, pharmacy technicians, PAs, physicians, and RNs accreditation and CE/CME:  - ACCME: 1.00 hour  - ACPE: 1.00 hour – pharmacists and technicians  - ANCC: 1.00 hour  [![Register Now](https://no-cache.hubspot.com/cta/default/229441/626bbc6b-fcbd-4614-bde8-45a895b1a6ae.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/626bbc6b-fcbd-4614-bde8-45a895b1a6ae) #### Pharmacy Essential Updates  **Upcoming 2026 Live Webinars** Check out our upcoming [Pharmacy Essential live CE webinars](https://learning.therapeuticresearch.com/course/view.php?id=7443).  Dates: July 14, 15, 18, 22, 30 **Topics for July include:** - Preventing motion sickness - Tick bites/Lyme disease - Expanding pharmacist and technician roles *Pharmacists and pharmacy technicians can earn 1 Hour of CE for each attended webinar.  [![Register Now](https://no-cache.hubspot.com/cta/default/229441/2478d1fe-2ec9-4d83-abe3-c338ea468645.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/2478d1fe-2ec9-4d83-abe3-c338ea468645) ### Popular Clinical Resources GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart ** ** Use our customizable chart to compare options and get guidance on switches. - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) - [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) Optimizing Care of Patients With Coronary Artery Disease ** ** Post our checklist for a comprehensive guide to care. - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Optimizing-Care-of-Patients-With-Coronary-Artery-Disease-11930) - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Optimizing-Care-of-Patients-With-Coronary-Artery-Disease-11930) - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Optimizing-Care-of-Patients-With-Coronary-Artery-Disease-11930) - [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Optimizing-Care-of-Patients-With-Coronary-Artery-Disease-11930) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Optimizing-Care-of-Patients-With-Coronary-Artery-Disease-11930) - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Optimizing-Care-of-Patients-With-Coronary-Artery-Disease-11930) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Optimizing-Care-of-Patients-With-Coronary-Artery-Disease-11930) Cholesterol Guidelines ** ** Keep our chart on hand as a quick reference to managing cholesterol for primary or secondary prevention. - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2014/Jan/Cholesterol-Guidelines-6474) - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2014/Jan/Cholesterol-Guidelines-6474) - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2014/Jan/Cholesterol-Guidelines-6474) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2014/Jan/Cholesterol-Guidelines-6474) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2014/Jan/Cholesterol-Guidelines-6474) Artificial Intelligence in Pharmacy Practice ** ** Review our resource for general AI concepts and guidance about potential uses in pharmacy practice. - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) - [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) Equianalgesic Dosing of Opioids for Pain Management ** ** Post our chart to help guide these complex switches. - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2015/Jul/Equianalgesic-Dosing-of-Opioids-for-Pain-Management-8635) - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2015/Jul/Equianalgesic-Dosing-of-Opioids-for-Pain-Management-8635) - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2015/Jul/Equianalgesic-Dosing-of-Opioids-for-Pain-Management-8635) - [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2015/Jul/Equianalgesic-Dosing-of-Opioids-for-Pain-Management-8635) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2015/Jul/Equianalgesic-Dosing-of-Opioids-for-Pain-Management-8635) - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2015/Jul/Equianalgesic-Dosing-of-Opioids-for-Pain-Management-8635) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2015/Jul/Equianalgesic-Dosing-of-Opioids-for-Pain-Management-8635) ### Now Available! Free Up Pharmacist Hours with Technician Product Verification Training  Pharmacy staff shortages and inconsistent technician training keep piling pressure on already strained systems. Expanding technician product verification offers a practical path forward—letting pharmacists practice at the top of their license by focusing on clinical care and patient services, while empowering technicians to take on greater responsibility. As more states authorize this practice, pharmacies that invest in structured verification training stand to gain a significant operational edge. Now available through the Pharmacy Technician Learning & Practice Suite, the new [**Technician Product Verification (TPV) program**](https://trchealthcare.com/group-purchases/technician-product-verification-tpv-training/) helps you build that edge while meeting evolving state requirements. It tackles training hurdles head-on by turning everyday verification practice into accredited CE credit and a clear certification path. And if you already use the technician suite, you should already have access. **With TPV training, your pharmacy gains**: - **Better-prepared technicians** through a 120-question visual drill bank that mirrors real verification scenarios and real misfill errors, including human, assumption, selection, and technical. - **Progress toward compliance** with accredited CE credit that counts against PTCB's 20-hour biennial renewal, including patient safety and pharmacy law hours. - **A clear path to certification** that's PTCB-recognized and built directly into the program, supporting retention and reducing turnover. - **Audit-ready records** with nationally portable credentials that stand up to state board review. Most CE courses check a box. The TPV Training Program builds real-world verification skill. [![Get the Details](https://no-cache.hubspot.com/cta/default/229441/84d11ece-3e68-4aee-a3fa-79ab5a5ef302.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/84d11ece-3e68-4aee-a3fa-79ab5a5ef302) #### Webinar Spotlight ##### **Pharmacy Turnover is Quietly Draining Capacity and Growth ** We’re excited to have partnered with **Becker’s Healthcare** for this webinar featuring our Chief Pharmacy Officer, **Dr.** **Tina Moen, PharmD**, and **Julie Lanza, CPhT-Adv, CSPT, CPTEd, FMSHP**, Director of Pharmacy Education and Training at Beth Israel Lahey Health. In this [**recorded session,**](https://trchealthcare.com/webinar-pharmacy-turnover-is-quietly-draining-capacity-and-growth/) Tina and Julie examine what leaders are missing about pharmacy workforce stability and why it increasingly shapes performance. The conversation moves past staffing metrics to the operational and financial impact of turnover, the forces reshaping the pharmacy workforce, and the strategies organizations are using to build stronger, more sustainable teams. [Watch Now](https://trchealthcare.com/webinar-pharmacy-turnover-is-quietly-draining-capacity-and-growth/) *Please note: This webinar is intended for educational and informational purposes only and does NOT offer CE/CME credit.* [![Watch Now](https://no-cache.hubspot.com/cta/default/229441/7fb1c108-63c2-498c-b2d4-6fedc8f5f3ff.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/7fb1c108-63c2-498c-b2d4-6fedc8f5f3ff) ##### **Connect with Us at an Upcoming Event** Join us at PTEC this weekend, July 9–11, or at NACDS next month. Meet with our experts, explore our pharmacy workforce solutions, and learn how leading organizations are improving compliance, workforce readiness, and patient care with TRC Healthcare. [ See Our Schedule ](https://trchealthcare.com/tradeshows-events/) ### About TRC Healthcare ###### TRC Healthcare provides unbiased education, training, and support to every healthcare professional to reduce knowledge gaps, encourage evidence-based practice, lower costs, and deliver better patient outcomes. ![](https://info.trchealthcare.com/hubfs/raw_assets/public/TRC/Images/logoIcon.svg) - [ Contact Us ](https://trchealthcare.com/contact-us/) - [ Privacy Policy ](https://info.trchealthcare.com/data-usage-policy) [![TRC Healthcare](https://info.trchealthcare.com/hubfs/_TRC%20Logos/TRC%20Healthcare/TRC%20Logo%20-%20LP.svg) ](https://www.trchealthcare.com) © 2026 TRC Healthcare. All Rights Reserved.